Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $226.05 USD
Change Today +0.53 / 0.24%
Volume 1.3M
MCK On Other Exchanges
Symbol
Exchange
New York
Mexico
As of 8:04 PM 03/26/15 All times are local (Market data is delayed by at least 15 minutes).

mckesson corp (MCK) Snapshot

Open
$225.14
Previous Close
$225.52
Day High
$229.22
Day Low
$223.62
52 Week High
03/23/15 - $232.69
52 Week Low
04/11/14 - $162.90
Market Cap
52.6B
Average Volume 10 Days
971.7K
EPS TTM
$8.23
Shares Outstanding
232.8M
EX-Date
02/26/15
P/E TM
27.5x
Dividend
$0.96
Dividend Yield
0.42%
Current Stock Chart for MCKESSON CORP (MCK)

mckesson corp (MCK) Details

McKesson Corporation delivers pharmaceuticals, medical supplies, and health care information technologies to the healthcare industry in the United States and internationally. The company operates in two segments, McKesson Distribution Solutions and McKesson Technology Solutions. The McKesson Distribution Solutions segment distributes ethical and proprietary drugs and equipment, and health and beauty care products. This segment also provides specialty pharmaceutical solutions for biotech and pharmaceutical manufacturers; and practice management, technology, clinical support, and business solutions to oncology and other specialty practices operating in the community setting. In addition, this segment offers medical-surgical supply distribution, equipment, logistics, and other services to healthcare providers through a network of distribution centers in the United States; sells financial, operational, and clinical solutions for pharmacies; and provides consulting, outsourcing, and other services. The McKesson Technology Solutions segment delivers enterprise-wide clinical, patient care, financial, supply chain, and strategic management software solutions; and connectivity, outsourcing, and other services, such as remote hosting and managed services to healthcare organizations. This segment also offers InterQual clinical criteria solution, claims payment solutions, and network performance tools. This segment’s customers include hospitals, physicians, homecare providers, retail pharmacies, and payers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

71,400 Employees
Last Reported Date: 05/14/14
Founded in 1833

mckesson corp (MCK) Top Compensated Officers

Chairman, Chief Executive Officer and Preside...
Total Annual Compensation: $1.7M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $2.0M
Executive Vice President and Group President
Total Annual Compensation: $1.1M
Executive Vice President and Group President
Total Annual Compensation: $684.0K
Principal Accounting Officer, Vice President ...
Total Annual Compensation: $623.1K
Compensation as of Fiscal Year 2014.

mckesson corp (MCK) Key Developments

McKesson Corporation Appoints Executives

McKesson Corporation announced that Bansi Nagji has been appointed executive vice president of corporate strategy and business development. Prior to joining Monitor, he worked as a solicitor in London with one of Europe's large law firms. Brian Tyler Promoted to President, North American Pharmaceutical Distribution and Services. Tyler, McKesson's former strategy chief, has fully transitioned to a new role that was created after McKesson's acquisition of the global pharmaceutical distribution company, Celesio.

McKesson Corporation Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended December 31, 2014; Provides Earnings Guidance for the Year Ending March 31, 2015

McKesson Corporation reported unaudited consolidated earnings results for the third quarter and nine months ended December 31, 2014. For the quarter, the company reported revenues of $47,005 million against $34,336 million a year ago. Operating income was $780 million compared to $493 million for the same period in the last year. Income from continuing operations before income taxes was $696 million compared to $418 million for the same period in the last year. Net income was $511 million compared to $65 million for the same period in the last year. Net income attributable to the company was $472 million or $2.00 per diluted share compared to $65 million or $0.28 per diluted share for the same period in the last year. Earnings per share attributable to the company from continuing operations diluted were $2.01 against $0.70 a year ago. On adjusted basis, the company reported income from continuing operations before income taxes was $697 million against $714 million a year ago. Income from continuing operations, net of tax, attributable to the company was $679 million against $347 million a year ago. Diluted earnings per common share from continuing operations, net of tax, attributable to the company was $2.89 against $1.48 a year ago. Operating profit was $1,166 million against $860 million a year ago. For the nine months, the company reported revenues of $135,821 million against $99,560 million a year ago. Operating income was $2,256 million compared to $1,834 million for the same period in the last year. Income from continuing operations before income taxes was $2,016 million compared to $1,656 million for the same period in the last year. Net income was $1,399 million compared to $893 million for the same period in the last year. Net income attributable to the company was $1,344 million or $5.72 per diluted share compared to $893 million or $3.83 per diluted share for the same period in the last year. Earnings per share attributable to the company from continuing operations diluted were $5.84 against $4.36 a year ago. On adjusted basis, the company reported income from continuing operations before income taxes was $2,851 million against $2,213 million a year ago. Income from continuing operations, net of tax, attributable to the company was $1,922 million against $1,372 million a year ago. Diluted earnings per common share from continuing operations, net of tax, attributable to the company was $8.17 against $5.89 a year ago. Operating profit was $2,150 million against $2,471 million a year ago. Net cash provided by operating activities was $1,229 million against $472 million a year ago. Property acquisitions were $286 million against $191 million a year ago. Capitalized software expenditures were $119 million against $108 million a year ago. Internal capital spending totaled $405 million for the first nine months of fiscal 2015. The company raised outlook for the year and now expect adjusted earnings per diluted share from continuing operations of $10.80 to $10.95 for the fiscal year ending March 31, 2015. The company now expects full year internal capital spending to be approximately $525 million. With respect to GAAP earnings per share for the full year, the company now expects $1.48 in amortization of acquisition-related intangible assets and $0.63 of acquisition expenses and related adjustments.

McKesson Corporation Declares Quarterly Dividend, Payable on April 1, 2015

The Board of Directors of McKesson Corporation declared a regular quarterly dividend of twenty-four cents per share on common stock. The dividend will be payable on April 1, 2015, to stockholders of record on March 2, 2015.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MCK:US $226.05 USD +0.53

MCK Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Aetna Inc $105.91 USD -1.38
AmerisourceBergen Corp $112.09 USD -0.05
Cardinal Health Inc $89.14 USD +0.13
Express Scripts Holding Co $82.99 USD -0.46
UnitedHealth Group Inc $116.25 USD -0.29
View Industry Companies
 

Industry Analysis

MCK

Industry Average

Valuation MCK Industry Range
Price/Earnings 30.8x
Price/Sales 0.3x
Price/Book 5.8x
Price/Cash Flow 30.6x
TEV/Sales 0.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MCKESSON CORP, please visit www.mckesson.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.